Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study

Authors

Francisco Fidencio Cons Molina
Pascale Pellet
Gustavo Aroca (ORCID: https://orcid.org/0000-0002-9222-3257)
Minghui Zhao (ORCID: https://orcid.org/0000-0003-2732-5721)
Maria G. Tektonidou (ORCID: https://orcid.org/0000-0003-2238-0975)
Anubhav Mathur
Thao Ngoc Phuong Huynh
Rui Sun (ORCID: https://orcid.org/0000-0003-0240-8811)
Ruvie Martin
Radhika Tangadpalli

Institutions

Novartis (Switzerland) (CH)
National and Kapodistrian University of Athens (GR)
Peking University (CN)
University of Medicine and Pharmacy at Ho Chi Minh City (VN)
Novartis (India) (IN)
University Medical Center HCMC (VN)
Novartis (United States) (US)
Peking University First Hospital (CN)
Universidad Simón Bolívar (CO)
Altoona Arthritis and Osteoporosis Center (US)
Tris Pharma (United States) (US)

Publication Details

Journal: Lara D. Veeken
Published: 2025-10-13
DOI: https://doi.org/10.1093/rheumatology/keaf536
Citations: 3
Primary Topic: Systemic Lupus Erythematosus Research
Type: article
Field-Weighted Citation Impact: 5.00

Funders

Novartis Pharma

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study

Francisco Fidencio Cons Molina, Pascale Pellet, Gustavo Aroca, Minghui Zhao et al.

Oct 13, 2025

3 citations

Lara D. Veeken

Systemic Lupus Erythematosus Research

5.00

article

Secukinumab in active lupus nephritis: results from a phase III randomized, placebo-controlled study (SELUNE) and an open-label extension study

Francisco Fidencio Cons Molina, Pascale Pellet, Gustavo Aroca, Minghui Zhao, Maria G. Tektonidou, Anubhav Mathur, Thao Ngoc Phuong Huynh, Rui Sun, Ruvie Martin, Radhika Tangadpalli

October 13, 2025article en

3 citations

Abstract

No abstract available for this paper.

Lara D. VeekenVol. 65(1)

Novartis (Switzerland) (CH), National and Kapodistrian University of Athens (GR), Peking University (CN), University of Medicine and Pharmacy at Ho Chi Minh City (VN), Novartis (India) (IN), University Medical Center HCMC (VN), Novartis (United States) (US), Peking University First Hospital (CN), Universidad Simón Bolívar (CO), Altoona Arthritis and Osteoporosis Center (US), Tris Pharma (United States) (US)

Novartis Pharma

Openalex Percentile: Top 4%

Systemic Lupus Erythematosus Research

5.00

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.